Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marvin E Reid

Showing results (21-30 of 25) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 25 results.
Psychology, Health & Medicine|January 18, 2013
Locus of control, depression and quality of life among persons with sickle cell disease in JamaicaRoger C Gibson, Kai A D Morgan, Wendel D Abel, et al.
JMIR Research Protocols|September 14, 2016
EXpanding Treatment for Existing Neurological Disease (EXTEND): An Open-Label Phase II Clinical Trial of Hydroxyurea Treatment in Sickle Cell AnemiaAngela E Rankine-Mullings, Courtney R Little, Marvin E Reid, et al.
American Journal of Hematology|September 29, 2015
Prevention of conversion to abnormal transcranial Doppler with hydroxyurea in sickle cell anemia: A Phase III international randomized clinical trialJane S Hankins, Mary Beth McCarville, Angela Rankine-Mullings, et al.
Nature Communications|December 21, 2019
Edematous severe acute malnutrition is characterized by hypomethylation of DNAKatharina V Schulze, Shanker Swaminathan, Sharon Howell, et al.
Blood Advances|September 30, 2025
Hydroxyurea pharmacokinetics in children with sickle cell anemia across different global populationsAlexandra Power-Hays, Kathryn E McElhinney, Thomas N Williams, et al.
Pageof 3

Showing results (21-30 of 25) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 25 results.
Psychology, Health & Medicine|January 18, 2013
Locus of control, depression and quality of life among persons with sickle cell disease in JamaicaRoger C Gibson, Kai A D Morgan, Wendel D Abel, et al.
JMIR Research Protocols|September 14, 2016
EXpanding Treatment for Existing Neurological Disease (EXTEND): An Open-Label Phase II Clinical Trial of Hydroxyurea Treatment in Sickle Cell AnemiaAngela E Rankine-Mullings, Courtney R Little, Marvin E Reid, et al.
American Journal of Hematology|September 29, 2015
Prevention of conversion to abnormal transcranial Doppler with hydroxyurea in sickle cell anemia: A Phase III international randomized clinical trialJane S Hankins, Mary Beth McCarville, Angela Rankine-Mullings, et al.
Nature Communications|December 21, 2019
Edematous severe acute malnutrition is characterized by hypomethylation of DNAKatharina V Schulze, Shanker Swaminathan, Sharon Howell, et al.
Blood Advances|September 30, 2025
Hydroxyurea pharmacokinetics in children with sickle cell anemia across different global populationsAlexandra Power-Hays, Kathryn E McElhinney, Thomas N Williams, et al.
Pageof 3